Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health, Inc. (NYSE: TDOC) is a global leader in whole-person virtual care, pioneering the transformation of the healthcare experience through its innovative telehealth platform. The company offers on-demand healthcare services via mobile devices, the internet, video, and phone, ensuring accessible and personalized medical care for everyone, everywhere.
Founded with a vision to empower individuals to live their healthiest lives, Teladoc Health utilizes proprietary health signals and data-driven insights to deliver superior health outcomes across the full continuum of care. This approach spans every stage of a person's health journey, from preventive care to chronic condition management.
The company operates primarily in two segments: Health Integrated Care and BetterHelp. The Health Integrated Care segment focuses on providing comprehensive healthcare services, while BetterHelp offers tailored mental health support. Revenue is generated predominantly through access fees on a subscription basis, complemented by visit fees and equipment rental and sales to hospital systems.
Teladoc Health has forged strategic partnerships with employers, health plans, and health systems, extending its network to millions of members globally. The company has also broadened its reach by marketing directly to consumers and continuously expanding its service offerings.
In recent years, Teladoc Health has been recognized for its excellence, including being ranked best in KLAS for Virtual Care Platforms in 2020. The company's robust financial performance is highlighted by an 8% revenue growth to $2,602.4 million in 2023 and a significant rise in adjusted EBITDA by 33% to $328.1 million. The company continues to innovate with integrated app experiences and provider-based chronic condition management, setting itself apart in the marketplace.
Noteworthy recent achievements include a new Comprehensive Weight Management solution designed to combat obesity-related health issues through a holistic approach that integrates medical, wellness, and technological support.
With a steadfast commitment to delivering world-class healthcare and expanding its offerings, Teladoc Health remains a pivotal player in the virtual care landscape, driving better health outcomes and improved quality of life for its users worldwide.
Teladoc Health (NYSE: TDOC) reported its Full Year and Fourth Quarter 2024 results, showing overall revenue decline. Full Year 2024 revenue decreased 1% to $2,569.6 million, while Q4 2024 revenue fell 3% to $640.5 million.
The company recorded a significant Full Year 2024 net loss of $1,001.2 million ($5.87 per share), including a non-cash goodwill impairment charge of $790.0 million related to BetterHelp segment. Q4 2024 net loss was $48.4 million ($0.28 per share).
Key performance metrics showed mixed results:
- Integrated Care segment revenue grew 2% to $390.7 million in Q4
- BetterHelp segment revenue declined 10% to $249.8 million
- Full Year adjusted EBITDA decreased 5% to $310.7 million
- Cash position stood at $1,298.3 million as of December 31, 2024
Teladoc Health (NYSE: TDOC), the global leader in virtual care, has announced its participation in the upcoming TD Cowen 45th Annual Health Care Conference in Boston. CEO Chuck Divita and CFO Mala Murthy will represent the company at the event, scheduled for March 3rd, 2025, at 10:30 a.m. ET.
Investors and interested parties can access a live audio webcast of the presentation through Teladoc Health's investor relations website. A replay of the presentation will also be made available at http://ir.teladochealth.com/news-and-events/events-and-presentations.
Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to two new non-executive employees. The awards, granted on February 1, 2025, consist of restricted stock units covering 35,000 shares of Teladoc's common stock. The vesting schedule includes one-third of the shares on the first anniversary of the grant date, with the remaining shares vesting quarterly over the subsequent two years, contingent on continued employment. The awards were approved by the Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.
Teladoc Health (NYSE: TDOC) has announced a definitive agreement to acquire Catapult Health for $65 million in cash, with an additional $5 million potential earnout. The acquisition aims to enhance Teladoc's preventive care and chronic care management capabilities through Catapult's VirtualCheckup program, which provides at-home diagnostic testing and virtual nurse practitioner consultations.
Catapult Health generated approximately $30 million in trailing twelve-month revenue as of Q3 2024 and serves hundreds of employers with over three million covered lives. The company's VirtualCheckup service has demonstrated strong results, including an 81+ Net Promoter Score and significant health impact, with 30% of members discovering high blood pressure and 28% learning of prediabetes for the first time.
The acquisition, expected to close in Q1 2025, aligns with Teladoc's integrated care strategy focusing on membership growth, healthcare outcomes improvement, international expansion, and mental health services advancement.
Teladoc Health (NYSE: TDOC) has scheduled its fourth quarter 2024 financial results announcement for Wednesday, February 26, 2025, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to review the results.
U.S. participants can join the conference call by dialing 1-833-470-1428 with access code #259200. International participants can find their dial-in numbers through a provided link. A live audio webcast will be available on the company's investor relations website, with a replay accessible for approximately 90 days following the call.
Teladoc Health (NYSE: TDOC) has announced a new collaboration with Amazon to expand access to its chronic condition programs through Amazon's Health Benefits Connector. Eligible customers can now discover and enroll in Teladoc's diabetes, hypertension, pre-diabetes, and weight management programs directly through Amazon's platform.
Teladoc currently has over 1 million active enrollees in its chronic condition programs, which combine connected devices, data-driven personalization, and expert coaching to promote better cardiometabolic health. The partnership aims to address the challenge of enrollment barriers, noting that nearly 25% of U.S. adults are unaware of their available health plan benefits.
The collaboration focuses on improving healthcare accessibility and simplifying the enrollment process, with both companies planning to explore additional opportunities to enhance consumer healthcare experiences.
Teladoc Health (NYSE: TDOC), the global leader in virtual care, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company will be represented by CEO Chuck Divita and CFO Mala Murthy at the event in San Francisco on January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET).
Interested parties can access a live audio webcast of the presentation, and a replay will be made available through the company's investor relations website at ir.teladochealth.com/news-and-events/events-and-presentations.
Teladoc Health (NYSE: TDOC) has launched enhanced AI capabilities for its Virtual Sitter solution to improve patient safety in hospitals. The new technology enables a single remote staff member to monitor up to 25% more patients, addressing the critical issue of hospital falls, which affect nearly 1 million patients annually and cost approximately $50 billion in medical expenses. The AI-enabled system uses advanced algorithms, motion detection, and pose estimation to detect potentially dangerous patient movements, allowing faster intervention. The solution runs on Teladoc's TV Pro devices using local processing for enhanced security and performance.
Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, announced its participation in the 36th Annual Piper Sandler Healthcare Conference. The event will take place in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. CEO Chuck Divita and CFO Mala Murthy will represent the company. A live audio webcast and replay of the presentation will be accessible through Teladoc's investor relations website.
Teladoc Health (NYSE:TDOC) has granted inducement awards to two new non-executive employees, effective November 1, 2024. The awards consist of restricted stock units covering 70,575 shares of common stock. The vesting schedule includes one-third of shares on the first anniversary, with the remaining shares vesting quarterly over the following two years. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
FAQ
What is the current stock price of Teladoc Health (TDOC)?
What is the market cap of Teladoc Health (TDOC)?
What services does Teladoc Health provide?
What are the main revenue sources for Teladoc Health?
What segments does Teladoc Health operate in?
Who are Teladoc Health’s partners?
How does Teladoc Health use technology to improve healthcare?
What recent innovations has Teladoc Health introduced?
What are Teladoc Health's latest financial highlights?
How does Teladoc Health support weight management?
What is Teladoc Health's mission?
Where can I find more information about Teladoc Health?
